Gimatecan | Interleukin Related interleukin-related.com

Product Name :
Gimatecan

Search keywords :
Gimatecan

drugId :
null

Target Vo:
DNA topoisomerase I

Target Vo Short Name :
TOP1

Moa_Name:
DNA topoisomerase I inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sigma-Tau Spa

Active Company_Name :
Lee’S Pharmaceutical Ltd

Active Indication_Name:
Peritoneal Neoplasms

In Active Indication_Name:
Myelodysplastic Syndromes

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cemiplimab Biological Activity
Botensilimab custom synthesis
Bcl2 Antibody (YA824): Bcl2 Antibody (YA824) is a non-conjugated and Mouse origined monoclonal antibody about 26 kDa, targeting to Bcl2 (1D8). It can be used for WB assays with tag free, in the background of Human, Rat, Mouse.

Author: Interleukin Related

Related Posts